150 related articles for article (PubMed ID: 8183250)
21. Release of N-[3H]methylscopolamine from isolated guinea pig atria is controlled by diffusion and rebinding.
Lüllmann H; Mohr K; Pfeffer J
J Pharmacol Exp Ther; 1988 Nov; 247(2):710-4. PubMed ID: 3183965
[TBL] [Abstract][Full Text] [Related]
22. Interaction of the neuromuscular blocking drug atracurium with muscarinic acetylcholine receptors.
Musílková J; Starshinova LA; Shelkovnikov SA; Tucek S
Physiol Res; 1991; 40(3):293-304. PubMed ID: 1751476
[TBL] [Abstract][Full Text] [Related]
23. Positive allosteric interactions on cardiac muscarinic receptors: effects of chemical modifications of disulphide and carboxyl groups.
Jakubík J; Tucek S
Eur J Pharmacol; 1995 Apr; 289(2):311-9. PubMed ID: 7621905
[TBL] [Abstract][Full Text] [Related]
24. Opposite effects of alcuronium on agonist and on antagonist binding to muscarinic receptors.
Maass A; Mohr K
Eur J Pharmacol; 1996 Jun; 305(1-3):231-4. PubMed ID: 8813558
[TBL] [Abstract][Full Text] [Related]
25. Characterization of [3H]Ba 679 BR, a slowly dissociating muscarinic antagonist, in human lung: radioligand binding and autoradiographic mapping.
Haddad EB; Mak JC; Barnes PJ
Mol Pharmacol; 1994 May; 45(5):899-907. PubMed ID: 8190106
[TBL] [Abstract][Full Text] [Related]
26. Characterization of 3H-N-methylscopolamine binding to intact rat thymocytes.
Rinner I; Porta S; Schauenstein K
Endocrinol Exp; 1990 Mar; 24(1-2):125-32. PubMed ID: 2361455
[TBL] [Abstract][Full Text] [Related]
27. The interaction between methylene blue and the cholinergic system.
Pfaffendorf M; Bruning TA; Batnik HD; van Zwieten PA
Br J Pharmacol; 1997 Sep; 122(1):95-8. PubMed ID: 9298533
[TBL] [Abstract][Full Text] [Related]
28. Influence of pH on the binding of scopolamine and N-methylscopolamine to muscarinic receptors in the corpus striatum and heart of rats.
Ehlert FJ; Delen FM
Mol Pharmacol; 1990 Jul; 38(1):143-7. PubMed ID: 2370852
[TBL] [Abstract][Full Text] [Related]
29. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
Flynn DD; Mash DC
Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
[TBL] [Abstract][Full Text] [Related]
30. Effects of d-tubocurarine on rat cardiac muscarinic receptors: a comparison with gallamine.
Waelbroeck M; Robberecht P; De Neef P; Christophe J
J Recept Res; 1988; 8(6):787-808. PubMed ID: 3193402
[TBL] [Abstract][Full Text] [Related]
31. Probing the selectivity of allosteric modulators of muscarinic receptors at other G-protein-coupled receptors.
Pfaffendorf M; Batink HD; Tränkle C; Mohr K; van Zwieten PA
J Auton Pharmacol; 2000 Feb; 20(1):55-62. PubMed ID: 11048962
[TBL] [Abstract][Full Text] [Related]
32. Assessment of the allosteric interactions of the bisquaternary heptane-1,7-bis(dimethyl-3'-phthalimidopropyl)ammonium bromide at M1 and M2 muscarine receptors.
Christopoulos A; Mitchelson F
Mol Pharmacol; 1994 Jul; 46(1):105-14. PubMed ID: 8058045
[TBL] [Abstract][Full Text] [Related]
33. Binding and functional characterization of the cardioselective muscarinic antagonist methoctramine.
Giraldo E; Micheletti R; Montagna E; Giachetti A; Viganò MA; Ladinsky H; Melchiorre C
J Pharmacol Exp Ther; 1988 Mar; 244(3):1016-20. PubMed ID: 3252019
[TBL] [Abstract][Full Text] [Related]
34. Allosteric stabilization of 3H-N-methylscopolamine binding in guinea-pig myocardium by an antidote against organophosphate intoxication.
Jepsen K; Lüllmann H; Mohr K; Pfeffer J
Pharmacol Toxicol; 1988 Sep; 63(3):163-8. PubMed ID: 3054859
[TBL] [Abstract][Full Text] [Related]
35. Divergent modes of action among cationic allosteric modulators of muscarinic M2 receptors.
Tränkle C; Mohr K
Mol Pharmacol; 1997 Apr; 51(4):674-82. PubMed ID: 9106634
[TBL] [Abstract][Full Text] [Related]
36. Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity.
Lazareno S; Dolezal V; Popham A; Birdsall NJ
Mol Pharmacol; 2004 Jan; 65(1):257-66. PubMed ID: 14722259
[TBL] [Abstract][Full Text] [Related]
37. Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist.
Grossmüller M; Antony J; Tränkle C; Holzgrabe U; Mohr K
Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):267-76. PubMed ID: 16362429
[TBL] [Abstract][Full Text] [Related]
38. Positive and negative allosteric interactions on muscarinic receptors.
Hejnová L; Tucek S; el-Fakahany EE
Eur J Pharmacol; 1995 Nov; 291(3):427-30. PubMed ID: 8719429
[TBL] [Abstract][Full Text] [Related]
39. Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells.
Cembala TM; Sherwin JD; Tidmarsh MD; Appadu BL; Lambert DG
Br J Pharmacol; 1998 Nov; 125(5):1088-94. PubMed ID: 9846649
[TBL] [Abstract][Full Text] [Related]
40. Identification of drugs competing with d-tubocurarine for an allosteric site on cardiac muscarinic receptors.
Waelbroeck M
Mol Pharmacol; 1994 Oct; 46(4):685-92. PubMed ID: 7969047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
